HIA
HFM Investment Advisors Portfolio holdings
AUM
$227M
This Quarter Return
+7.3%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$227M
AUM Growth
+$21.3M
(+10%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-64%
Top 10 Holdings %
Top 10 Hldgs %
95.48%
Holding
1,329
New
140
Increased
1,034
Reduced
41
Closed
42
Top Buys
Top Sells
Sector Composition
| 1 | Industrials | 1.01% |
| 2 | Technology | 0.77% |
| 3 | Healthcare | 0.61% |
| 4 | Utilities | 0.25% |
| 5 | Energy | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Guardant Health
GH
$7.5B
| $260 | ﹤0.01% |
5
+4
| +400% | +$208 |
|
902
Ameris Bancorp
ABCB
$5.08B
| $259 | ﹤0.01% |
4
+2
| +100% | +$130 |
|
903
National Beverage
FIZZ
$3.75B
| $259 | ﹤0.01% |
6
+4
| +200% | +$173 |
|
904
Lumen
LUMN
$4.87B
| $258 | ﹤0.01% |
59
+46
| +354% | +$201 |
|
905
Novanta
NOVT
$4.18B
| $258 | ﹤0.01% |
2
+1
| +100% | +$129 |
|
906
Alkermes
ALKS
$4.94B
| $257 | ﹤0.01% |
9
+5
| +125% | +$143 |
|
907
EnerSys
ENS
$3.89B
| $257 | ﹤0.01% |
3
+2
| +200% | +$171 |
|
908
Zurn Elkay Water Solutions
ZWS
$7.71B
| $256 | ﹤0.01% |
7
+5
| +250% | +$183 |
|
909
MSC Industrial Direct
MSM
$5.14B
| $255 | ﹤0.01% |
3
+1
| +50% | +$85 |
|
910
Worthington Enterprises
WOR
$3.24B
| $255 | ﹤0.01% |
4
+3
| +300% | +$191 |
|
911
Choice Hotels
CHH
$5.41B
| $254 | ﹤0.01% |
2
+1
| +100% | +$127 |
|
912
Devon Energy
DVN
$22.1B
| $254 | ﹤0.01% |
8
+2
| +33% | +$64 |
|
913
Green Brick Partners
GRBK
$3.2B
| $252 | ﹤0.01% |
4
+3
| +300% | +$189 |
|
914
Biogen
BIIB
$20.6B
| $251 | ﹤0.01% |
2
+1
| +100% | +$126 |
|
915
Repligen
RGEN
$7.01B
| $249 | ﹤0.01% |
2
| – | – |
|
916
Telephone and Data Systems
TDS
$4.54B
| $249 | ﹤0.01% |
7
+5
| +250% | +$178 |
|
917
BancFirst
BANF
$4.47B
| $247 | ﹤0.01% |
2
+1
| +100% | +$124 |
|
918
Lantheus
LNTH
$3.72B
| $246 | ﹤0.01% |
3
+2
| +200% | +$164 |
|
919
Robert Half
RHI
$3.77B
| $246 | ﹤0.01% |
6
+5
| +500% | +$205 |
|
920
Knife River
KNF
$4.55B
| $245 | ﹤0.01% |
3
+1
| +50% | +$82 |
|
921
Permian Resources
PR
$9.75B
| $245 | ﹤0.01% |
+18
| New | +$245 |
|
922
Humana
HUM
$37B
| $244 | ﹤0.01% |
1
| – | – |
|
923
PTC Therapeutics
PTCT
$4.55B
| $244 | ﹤0.01% |
5
+3
| +150% | +$146 |
|
924
Bio-Rad Laboratories Class A
BIO
$8B
| $241 | ﹤0.01% |
+1
| New | +$241 |
|
925
Genworth Financial
GNW
$3.52B
| $241 | ﹤0.01% |
31
+19
| +158% | +$148 |
|